Icahn School of Medicine at Mount Sinai - Nash Department of Neuroscience; Icahn School of Medicine at Mount Sinai - Ronald M. Loeb Center for Alzheimer's Disease
Icahn School of Medicine at Mount Sinai - Nash Department of Neuroscience; Icahn School of Medicine at Mount Sinai - Ronald M. Loeb Center for Alzheimer's Disease
Mount Sinai Health System, Icahn School of Medicine, Nash Department of Neuroscience; Mount Sinai Health System, Icahn School of Medicine, Ronald M. Loeb Center for Alzheimer's Disease
Mount Sinai Health System, Icahn School of Medicine, Nash Department of Neuroscience; Mount Sinai Health System, Icahn School of Medicine, Ronald M. Loeb Center for Alzheimer's Disease
Mount Sinai Health System, Icahn School of Medicine, Nash Department of Neuroscience; Mount Sinai Health System, Icahn School of Medicine, Ronald M. Loeb Center for Alzheimer's Disease
Mount Sinai Health System, Icahn School of Medicine, Nash Department of Neuroscience; Mount Sinai Health System, Icahn School of Medicine, Ronald M. Loeb Center for Alzheimer's Disease
Mount Sinai Health System, Icahn School of Medicine, Nash Department of Neuroscience; Mount Sinai Health System, Icahn School of Medicine, Ronald M. Loeb Center for Alzheimer's Disease
Icahn School of Medicine at Mount Sinai - Nash Department of Neuroscience; Icahn School of Medicine at Mount Sinai - Ronald M. Loeb Center for Alzheimer's Disease; Icahn School of Medicine at Mount Sinai - Department of Genetics and Genomic Sciences
Apolipoprotein E (APOE) ε4 is the strongest genetic risk factor for Alzheimer's disease (AD). Although its association with AD is well-established, the impact of APOE ε4 on human brain cell function remains unclear. Here we investigated the effects of APOE ε4 on brain cell types derived from human induced pluripotent stem cells and human APOE targeted replacement mice. Global transcriptomic profiles showed that APOE ε4 is associated with dysregulation of cholesterol homeostasis in human but not mouse glia. Elevated matrisome signaling in APOE ε4 mixed neuron/astrocyte cultures parallels altered pathways uncovered in cell-type deconvoluted APOE ε4 glia and AD post-mortem brains. In vitro study showed that isogenic APOE ε4 is associated with increased lysosomal cholesterol levels and decreased cholesterol efflux, demonstrating decoupled lipid metabolism. APOE ε4 glia also secrete higher levels of proinflammatory chemokines/cytokines, indicative of glial activation. Thus, APOE ε4 induces human glia-specific dysregulation that may initiate AD risk.
TCW, Julia and Liang, Shuang A. and Qian, Lu and Pipalia, Nina H. and Chao, Michael J. and Bertelsen, Sarah E. and Kapoor, Manav and Marcora, Edoardo and Sikora, Elizabeth and Holtzman, David and Maxfield, Frederick R. and Zhang, Bin and Wang, Minghui and Poon, Wayne W. and Goate, Alison M., Cholesterol and Matrisome Pathways Dysregulated in Human APOE ∊4 Glia (August 10, 2019). Available at SSRN: https://ssrn.com/abstract=3435267 or http://dx.doi.org/10.2139/ssrn.3435267
This version of the paper has not been formally peer reviewed.
Subscribe to this free journal for more curated articles on this topic
FOLLOWERS
16
PAPERS
7,972
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.